AstraZeneca PLC Pays $5.5 Million to Settle Kentucky Medicaid Fraud Suit
Published: Feb 08, 2013
Kentucky will be receiving $5.5 million in settlement money from AstraZeneca Pharmaceuticals LP to resolve allegations the company marketed one of their drugs incorrectly. Attorney General Jack Conway says Astra Zeneca marketed Seroquel, an atypical antipsychotic drug, for uses not cleared by the Food and Drug Administration. “I am pleased that we have reached this settlement and are recovering millions of dollars for a vital state program and for taxpayers,” General Conway said.